PAPER Zimny A, Szewczyk P, Bladowska J, Trypka E, Wojtynska R, Leszek J, Sasiadek M
SEARCH RESULTS
330029 RESULTS
PAPER Chen R, Young K, Chao LL, Miller B, Yaffe K, Weiner MW, Herskovits EH
Prediction of conversion from mild cognitive impairment to Alzheimer disease based on bayesian data mining with ensemble learning.
Neuroradiol J. 2012 Mar;25(1):5-16. PubMed: 24028870PAPER Gattaz WF, Talib LL, Schaeffer EL, Diniz BS, Forlenza OV
Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study.
J Neural Transm. 2013 Sep 15; PubMed: 24036895PAPER Mansouri MT, Naghizadeh B, Ghorbanzadeh B, Farbood Y, Sarkaki A, Bavarsad K
Gallic acid prevents memory deficits and oxidative stress induced by intracerebroventricular injection of streptozotocin in rats.
Pharmacol Biochem Behav. 2013 Oct;111:90-6. PubMed: 24036471PAPER Zhou W, Hu W
Anti-neuroinflammatory agents for the treatment of Alzheimer's disease.
Future Med Chem. 2013 Sep;5(13):1559-71. PubMed: 24024948PAPER Boyle PA, Yu L, Wilson RS, Segawa E, Buchman AS, Bennett DA
Cognitive decline impairs financial and health literacy among community-based older persons without dementia.
Psychol Aging. 2013 Sep;28(3):614-24. PubMed: 23957225PAPER Cheng F, Ruscher K, Fransson LÅ, Mani K
Non-toxic amyloid beta formed in the presence of glypican-1 or its deaminatively generated heparan sulfate degradation products.
Glycobiology. 2013 Dec;23(12):1510-9. PubMed: 24026238PAPER Liu L, Wang SY
[Protective effects of paeoniflorin against aBETA25-35-induced oxidative stress in PC12 cells].
Zhongguo Zhong Yao Za Zhi. 2013 May;38(9):1318-22. PubMed: 23944060PAPER Xue Y, Wan PT, Hillertz P, Schweikart F, Zhao Y, Wissler L, Dekker N
X-ray Structural Analysis of Tau-Tubulin Kinase 1 and Its Interactions with Small Molecular Inhibitors.
ChemMedChem. 2013 Sep 13; PubMed: 24039150PAPER Lenz S, Karsten P, Schulz JB, Voigt A
Drosophila as a screening tool to study human neurodegenerative diseases.
J Neurochem. 2013 Nov;127(4):453-60. PubMed: 24028575PAPER Morozova OA, March ZM, Robinson AS, Colby DW
Conformational features of tau fibrils from Alzheimer's disease brain are faithfully propagated by unmodified recombinant protein.
Biochemistry. 2013 Sep 27; PubMed: 24033133PAPER Zhelev Z, Bakalova R, Aoki I, Lazarova D, Saga T
Imaging of Superoxide Generation in the Dopaminergic Area of the Brain in Parkinson's Disease, Using Mito-TEMPO.
ACS Chem Neurosci. 2013 Sep 16; PubMed: 24024751PAPER Hensley K, Gabbita SP, Venkova K, Hristov A, Johnson MF, Eslami P, Harris-White ME
A Derivative of the Brain Metabolite Lanthionine Ketimine Improves Cognition and Diminishes Pathology in the 3×Tg-AD Mouse Model of Alzheimer Disease.
J Neuropathol Exp Neurol. 2013 Oct;72(10):955-69. PubMed: 24042198PAPER Blair LJ, Zhang B, Dickey CA
Potential synergy between tau aggregation inhibitors and tau chaperone modulators.
Alzheimers Res Ther. 2013 Sep 16;5(5):41. PubMed: 24041111PAPER Kosenko EA, Solomadin IN, Reddy VP, Aliev G, Kaminsky YG
Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid Beta Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism.
CNS Neurol Disord Drug Targets. 2013 Sep 16; PubMed: 24040810Current Filters
No filters selected